Skip links
Companies
› United States › RENEO PHARMACEUTICALS, INC.

RENEO PHARMACEUTICALS, INC.

Active

Registration No.
3768244
Incorporation Date
2015-03-18
Company Type
Not disclosed
Address
IRVINE, United States
Website
N/A
Source: California Secretary of State — bizfile Online

RENEO PHARMACEUTICALS, INC. is a registered legal entity registered in United States under 3768244, and its current status with California Secretary of State — bizfile Online is active. The company was incorporated on 18 March 2015 and lists its registered address as IRVINE, United States. 5 shareholders are on record for RENEO PHARMACEUTICALS, INC., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from California Secretary of State — bizfile Online and was last updated on 21 October 2026.

Data Provenance
This record is sourced directly from official government registries, including California Secretary of State — bizfile Online.

View data sources →

We don’t stop at registry data.
Every company record is enriched with additional intelligence:
  • Company fundamentals
  • Corporate linkage & group structures
  • Digitized company financials
  • Firmographics — websites, social profiles, revenue and employee estimates

View full data dictionary →

Shareholders

5

Five shareholders are currently on record for RENEO PHARMACEUTICALS, INC., reflecting the stock ledger kept by the company under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.

The largest of these is NEA Management Company, LLC, holding 18.7% — the largest recorded stake — followed by Novo Holdings A/S at 13%; the remaining 3 shareholders shown hold smaller stakes.

The register reports 20 shareholders in total, though only the top 5 by holding are shown in this view.

Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Shareholder Type Holding Source Document
NEA Management Company, LLC 18.7% California Secretary of State — bizfile Online
Novo Holdings A/S 13% California Secretary of State — bizfile Online
Carlyle Group Inc. 10.6% California Secretary of State — bizfile Online
Rivervest Venture Management LLC 9.9% California Secretary of State — bizfile Online
Octagon Capital Advisors LP 9.3% California Secretary of State — bizfile Online

View all shareholders & beneficial ownership
Full cap table, ownership percentages, and ultimate beneficial owners resolved down to the natural person.

View all shareholders →

Officers

5

The Founder & Executive Chairman of RENEO PHARMACEUTICALS, INC. currently on record is Michael G. Grey; five officers are currently on record for RENEO PHARMACEUTICALS, INC., filed with California Secretary of State — bizfile Online.

The register reports 14 officers in total, including past appointments, though only the 5 most relevant records are shown here.

Management authority at RENEO PHARMACEUTICALS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.

MG
Michael G. Grey ACTIVE

Residence
🇺🇸 United States
Occupation
Founder & Executive Chairman

GJ
Gregory J. Flesher ACTIVE

Residence
🇺🇸 United States
Occupation
President, Ceo & Director

AD
Alejandro Dorenbaum M.d. ACTIVE

Residence
🇺🇸 United States
Occupation
Chief Medical Officer

MP
Michael P. Cruse ACTIVE

Residence
🇺🇸 United States
Occupation
Chief Operating Officer

JP
Jennifer P. Lam ACTIVE

Residence
🇺🇸 United States
Occupation
Svp Of Finance & Administration And Principal Financial & Accounting Officer

View all officers & directors
Complete appointment history, representation authority, and officer-level filings across jurisdictions.

View all officers →

Need the full UBO picture on RENEO PHARMACEUTICALS, INC.?

Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.

Frequently Asked Questions

Who owns RENEO PHARMACEUTICALS, INC.?

Five shareholders are currently on record for RENEO PHARMACEUTICALS, INC., reflecting the stock ledger kept by the company under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is NEA Management Company, LLC, holding 18.7% — the largest recorded stake — followed by Novo Holdings A/S at 13%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Who is RENEO PHARMACEUTICALS, INC.'s UBO (Ultimate Beneficial Owner)?

Every shareholder recorded for RENEO PHARMACEUTICALS, INC. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.

How many shareholders does RENEO PHARMACEUTICALS, INC. have on record?

5 shareholders are shown on record for RENEO PHARMACEUTICALS, INC.. The register reports 20 in total; only the top 5 by holding are shown here.

What is RENEO PHARMACEUTICALS, INC.'s company registration number?

RENEO PHARMACEUTICALS, INC.'s registration number is 3768244, filed with California Secretary of State — bizfile Online in United States. Its current status on the register is active.

Is RENEO PHARMACEUTICALS, INC. still an active company?

RENEO PHARMACEUTICALS, INC.'s status on California Secretary of State — bizfile Online is listed as active.

When was RENEO PHARMACEUTICALS, INC. incorporated?

RENEO PHARMACEUTICALS, INC. was incorporated on 18 March 2015, according to California Secretary of State — bizfile Online.

What is RENEO PHARMACEUTICALS, INC.'s registered address?

The registered address on file for RENEO PHARMACEUTICALS, INC. is IRVINE, United States.

Who are the officers/directors of RENEO PHARMACEUTICALS, INC.?

The Founder & Executive Chairman of RENEO PHARMACEUTICALS, INC. currently on record is Michael G. Grey; five officers are currently on record for RENEO PHARMACEUTICALS, INC., filed with California Secretary of State — bizfile Online. Management authority at RENEO PHARMACEUTICALS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

Can Zavia monitor changes to RENEO PHARMACEUTICALS, INC.'s ownership over time?

This profile reflects a point-in-time snapshot from California Secretary of State — bizfile Online. Zavia's monitoring API can track changes to RENEO PHARMACEUTICALS, INC.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.

Can I access RENEO PHARMACEUTICALS, INC.'s data through an API?

Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like RENEO PHARMACEUTICALS, INC.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.

Where does this company information come from, and how current is it?

This record is sourced directly from California Secretary of State — bizfile Online and was last synced on 21 October 2026.

This website uses cookies to improve your web experience.